• Pemetrexed Workflows for Mesothelioma Research

  2026-08-14

  Build reproducible Pemetrexed dose–response, viability, and combination assays around folate-pathway inhibition rather than relying on a single endpoint. This workflow connects pemetrexed disodium exposure with malignant mesothelioma model selection, DNA-repair phenotyping, and practical troubleshooting for translational cancer chemotherapy research.

• Nicotine Signaling in Chronic Kidney Disease

  2026-08-13

  Jain and Jaimes synthesize clinical and experimental evidence that nicotine is more than a marker of tobacco exposure: it can directly activate renal nicotinic acetylcholine receptors, increase oxidative injury, and promote fibrotic pathways. The review provides a mechanism-oriented framework for separating nicotine effects from the broader toxicity of cigarette smoke and for designing kidney injury studies with receptor, redox, and fibrosis readouts.

• USP42, JNK/p38 Apoptosis, and Breast Cancer Progression

  2026-08-13

  The reference study identifies USP42 as an upregulated deubiquitinating enzyme that supports breast cancer growth by suppressing JNK/p38-associated apoptosis. Its combination of cell-based perturbation, pathway inhibition, and xenograft analysis provides a mechanistic framework for evaluating USP42 as a potential therapeutic target, while also highlighting important limits in causal interpretation.

• Recombinant Human IL-15 in Translational Immunology

  2026-08-12

  A thought-leadership guide to using Recombinant Human IL-15 as a controlled immune perturbation tool, connecting T and NK cell assay design with emerging neuroimmune questions raised by early life adversity research.

• CCT007093: Practical PPM1D Assay Guidance

  2026-08-12

  Learn how CCT007093 (SKU B3274) can support controlled studies of PPM1D, P38 MAPK signaling, cell viability, and cytotoxicity. Scenario-based guidance covers solvent compatibility, exposure timing, pathway validation, data interpretation, and vendor selection.

• MitMAB for Intestinal Organoid Endocytosis Studies

  2026-08-11

  MitMAB enables controlled perturbation of dynamin-dependent uptake in physiologically relevant intestinal organoids. Pairing this inhibitor with milk-derived extracellular vesicle assays helps distinguish apical accessibility, vesicle internalization, and downstream epithelial responses.

• SB525334 in TGF-beta1 Wound Models

  2026-08-10

  SB525334 enables receptor-level dissection of TGF-β1 signaling in fibrosis, renal disease, and diabetic wound-repair assays. This guide connects Smad2/3 phosphorylation inhibition with practical cell, tissue, and translational workflows while highlighting timing, vehicle, and interpretation controls.

• RG108 DNA Methyltransferase Inhibitor Workflow

  2026-08-09

  RG108 provides a non-covalent route to DNA methylation control for cell-based epigenetics, from leukemia-model pilot studies to mouse embryonic stem-cell differentiation assays. This workflow translates a reference study’s Lhx1-focused strategy into practical dosing, controls, readouts, and troubleshooting decisions.

• LRPPRC–Dasatinib Dual OXPHOS Disruption

  2026-08-08

  A 2026 study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. The proposed mechanism is a complementary dual-genome blockade: dasatinib suppresses nuclear-encoded OXPHOS programs, whereas LRPPRC inhibition preferentially disrupts mitochondrial genome-encoded OXPHOS genes.

• CHIR-99021 (CT99021): GSK-3 Inhibitor Guide

  2026-08-07

  CHIR-99021, also called CT99021, is a selective GSK-3α/β inhibitor used to modulate Wnt/β-catenin signaling and stem-cell fate. Its strongest applications are context-dependent pluripotency maintenance and timed differentiation, including cardiomyogenic differentiation of human ESCs.

• Oxidative Stress Drives Ferroptosis in Tendon Stem Cells via

  2026-08-07

  This study uncovers how oxidative stress induces ferroptosis in tendon stem cells (TSCs) through mitophagy regulated by the cGAS-STING pathway. The findings offer mechanistic insights into tendinopathy progression and highlight new intervention targets for tendon degeneration.

• AZD8055: Technical Guide for mTOR Inhibition in Research

  2026-08-06

  AZD8055 is a potent, dual mTORC1/mTORC2 inhibitor optimized for dissecting mTOR signaling in preclinical cancer and metabolic studies. It is suitable for workflows requiring selective mTOR kinase inhibition but not for applications demanding water solubility or clinical efficacy endpoints.

• EZ Cap™ Firefly Luciferase mRNA: Enabling Next-Gen Cytosolic

  2026-08-06

  Explore how EZ Cap™ Firefly Luciferase mRNA, featuring a Cap 1 structure, advances cytosolic delivery and translation efficiency assays. This article uniquely integrates recent nanovector research with practical workflow guidance for molecular biology and in vivo imaging.

• Linezolid in Antimicrobial Research: Applied Workflows & Ins

  2026-08-05

  Linezolid empowers advanced modeling of multidrug-resistant Gram-positive infections in preclinical research thanks to its potent, broad-spectrum activity and precise inhibition of bacterial protein synthesis. This guide translates recent reference breakthroughs and workflow innovations into actionable, troubleshooting-enriched protocols for MRSA, VRE, and pneumonia research.

• Metoprolol Tartrate (SKU B1339): Reliable β1 Blockade in Res

  2026-08-05

  This article delivers a scenario-driven, scientific exploration of how Metoprolol Tartrate (SKU B1339) ensures reliable β1-adrenergic receptor inhibition across cardiovascular and hematopoietic research. By addressing real lab challenges, it demonstrates how APExBIO’s high-purity, well-characterized compound supports reproducible data and informed assay optimization.

451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page